COMPASS Pathways plc

CRL AI-extracted

COMP360

treatment-resistant depression (TRD)

Countdown

177days

FDA decision · ~ Dec 31, 2026 estimated

What's at stake An FDA complete response letter on COMP360 for treatment-resistant depression (TRD) is in focus around ~ Dec 31, 2026.

Primary source · SEC 8-K verified 17h ago

“COMP360 has the potential to offer a highly differentiated, transformative clinical profile and is expected to be a blockbuster opportunity.”